Showing results (371-380 of 414) with videos related to
Sort By:
Pageof 42
Nature Immunology|April 19, 2022
PD-L1-PD-1 interactions limit effector regulatory T cell populations at homeostasis and during infectionJoseph A Perry, Lindsey Shallberg, Joseph T Clark, et al.Immunity|August 18, 2016
Programmed Death-1 Ligand 2-Mediated Regulation of the PD-L1 to PD-1 Axis Is Essential for Establishing CD4(+) T Cell ImmunityDeshapriya S Karunarathne, Joshua M Horne-Debets, Johnny X Huang, et al.Cell Chemical Biology|September 16, 2023
Metabolic modulation of mitochondrial mass during CD4+ T cell activationKiran Kurmi, Dan Liang, Robert van de Ven, et al.Nature Immunology|October 23, 2019
Fibroblastic reticular cells enhance T cell metabolism and survival via epigenetic remodelingFlavian D Brown, Debattama R Sen, Martin W LaFleur, et al.Nature Immunology|January 13, 2026
Stability and progressive differentiation of TFR cells are intrinsically and extrinsically controlled by TFH programsJeong-Mi Lee, Paulo Lisboa Raeder, Ridwan B Rashid, et al.Cell|August 9, 2024
LAG-3 and PD-1 synergize on CD8+ T cells to drive T cell exhaustion and hinder autocrine IFN-γ-dependent anti-tumor immunityLawrence P Andrews, Samuel C Butler, Jian Cui, et al.Cancer Immunology Research|August 26, 2024
Age-Associated Contraction of Tumor-Specific T Cells Impairs Antitumor ImmunityPeter Georgiev, SeongJun Han, Amy Y Huang, et al.Cell|September 12, 2015
Melanoma Cell-Intrinsic PD-1 Receptor Functions Promote Tumor GrowthSonja Kleffel, Christian Posch, Steven R Barthel, et al.Nature|July 21, 2017
In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy targetRobert T Manguso, Hans W Pope, Margaret D Zimmer, et al.Blood|October 4, 2018
Small-molecule BCL6 inhibitor effectively treats mice with nonsclerodermatous chronic graft-versus-host diseaseKatelyn Paz, Ryan Flynn, Jing Du, et al.Pageof 42